Show simple item record

FieldValueLanguage
dc.contributor.authorBasile, Kerri Michelle
dc.date.accessioned2024-06-21T01:13:40Z
dc.date.available2024-06-21T01:13:40Z
dc.date.issued2023en_AU
dc.identifier.urihttps://hdl.handle.net/2123/32692
dc.descriptionIncludes publication
dc.description.abstractThe emergence of novel pathogens, particularly those of pandemic potential, requires large public health laboratories with expertise to lead the early development of accurate diagnostics to identify cases to enable a timely public health response. Diagnostic assays need to be designed, validated, distributed and implemented in a timely manner. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent declaration of the coronavirus disease 2019 (COVID-19) pandemic in March 2020 has seen unprecedented demands placed on healthcare systems worldwide with laboratories placed under constant pressure to expand capacity to meet rising testing demands. The primary objective of this thesis, undertaken in a large diagnostic public health laboratory, is to address knowledge gaps in diagnostics and prognostics of SARS-CoV-2 infection, and tackle new challenges posed by ongoing viral evolution with evolving public health priorities and orders in response to the COVID-19 pandemic. This thesis highlights the use and performance of different laboratory methods including nucleic acid amplification testing, virus isolation and whole genome sequencing to diagnose and characterise SARS-CoV-2 and examines their application to prognosticate, inform infectivity, detect vaccine escape, antiviral resistance and virus transmission. Manuscripts were published in real time, allowing rapid dissemination of emerging evidence; this was used to inform local, state and national policy decisions around pandemic management. With continual evolution of SARS-CoV-2, along with the introduction of novel treatments and vaccines, there is a need for refinement of currently available assays as well as the ongoing paired phenotypic and genotypic assessment of novel lineages to inform clinical management and public health responses. The COVID-19 pandemic reaffirmed the need for reliable and effective diagnostics as the cornerstone of a successful outbreak response.en_AU
dc.language.isoenen_AU
dc.subjectSARS-CoV-2en_AU
dc.subjectCOVID-19en_AU
dc.subjectlaboratory diagnosticsen_AU
dc.subjectwhole genome sequencingen_AU
dc.subjectviral isolationen_AU
dc.subjectnucleic acid amplification testingen_AU
dc.titleDiagnostic, prognostic and predictive markers of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19)en_AU
dc.typeThesis
dc.type.thesisDoctor of Philosophyen_AU
dc.rights.otherThe author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.en_AU
usyd.facultySeS faculties schools::Faculty of Medicine and Healthen_AU
usyd.departmentWestmead Clinical Schoolen_AU
usyd.degreeDoctor of Philosophy Ph.D.en_AU
usyd.awardinginstUniversity of Sydneyen_AU
usyd.advisorDwyer, Dominic
usyd.advisorSintchenko, Vitali
usyd.advisorRockett, Rebecca
usyd.include.pubYesen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.